Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Guben tongye granule is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Henan Province Hospital of TCM. It is formulated specifically for the treatment of advanced esophageal cancer, particularly in patients who are unable to tolerate standard chemotherapy or whose disease has progressed following conventional treatment. The name reflects its therapeutic principles: 'Fuzheng Guben' refers to strengthening the body's resistance and consolidating the constitution, while 'Tongye' refers to relieving esophageal obstruction and dysphagia. The granule is evaluated for its ability to improve clinical benefit rates, enhance quality of life (QoL), and modulate immune function in patients with esophageal malignancies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzheng Guben tongye granule.